Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Applied Materials -- Ignore unavailable to you. Want to Upgrade?

To: willcousa who wrote (63957)	5/23/2002 2:06:24 PM
From: Jacob Snyder	Read Replies (1) \| Respond to of 70976

OT Biotech: Yes, I don't really see any way the Luddites can have a complete victory. But they will have a lot of local wins, lots of areas where they can delay introduction of a product for many years, and add a lot of costs for the companies who are developing the technology. They add a lot to the Event Risk in this sector. For instance, I watched Monsanto for several years, as they looked to be on track to roll up the ag biotech sector. But European housewives who didn't want to feed their babies "Frankenfood" successfully destroyed Monsanto's business plan (and destroyed the company as well). This is a cautionary tale that anyone investing in biotech, needs to keep in mind. Eventually, this technology will be pervasive in our lives, and the next Microsoft will likely be a biotech. But the road there will be strewn with more Monsantos. Biotech computers are, IMO, so far in the future there isn't much point in discussing it. For the next 10 years, biotech will expand its footprint in the pharm, medical testing, and (possibly) ag sectors. The other sectors I listed, are still BlueSky.